Desmovital (Desmopressin) Nasal Spray: Treating Frequent Urination and Diabetes Insipidus

Frequently waking to urinate at night disrupts sleep and may adversely affect the heart, kidneys, and hormonal system . This is called nocturia and may be associated with older age, diabetes, urinary tract infections, or conditions such as diabetes insipidus (DI) .

Diabetes insipidusis also colloquially called "diabetes without sugar." The kidneys cannot retain enough water, causing excessive urine production. This results from insufficient secretion or ineffective action of vasopressin (antidiuretic hormone) , which normally regulates kidney water balance. A person may pass up to 5–10 liters of urine daily and experience extreme thirst.

Desmovital nasal spraycontains desmopressin acetate . Desmopressin is a laboratory-synthesized analog of natural vasopressin. It increases renal water reabsorption, reduces urine production, and improves sleep.

Its brand name is Desmovital %0.1 mg/ml Nasal Spray. Each spray contains 10 micrograms of desmopressin acetate. It comes in a clear glass bottle with an automatic nasal pump. Particularly in central diabetes insipidus or excessive nighttime urine production, it helps balance water loss.

How Is It Used?

• Starting dose: 30–60 minutes before bedtime, 1 spray (10 µg) into one nostril.
• It is rapidly absorbed through the nasal lining and reduces urine production overnight.
• Ensure the nose is clear and clean before use.
• Alternate nostrils to prevent irritation.

If your doctor considers it appropriate, based on morning urine volume, the dose may be increased . Do not change the dose yourself.

⚠️ What Requires Attention?

• The drug increases water retention, so drinking too much fluid may be dangerous.
• Tell your doctor about headache, nausea, muscle cramps, or dizziness.
• Colds or nasal congestion may reduce absorption; your doctor may temporarily recommend switching to tablets .
• This medicine requires regular blood tests because of hyponatremia (low sodium) risk.

📊 Monitoring During Treatment

• On day 2, day 7, and at month 1, sodium monitoring is recommended.
• Urine volume generally normalizes within a few days, around 2–3 L/day.
• Dose adjustment is needed if urine output becomes very low or morning weakness is excessive.

🚫 Who Should Not Use It?

• People with kidney failure (creatinine clearance < 50 mL/min),
• Heart failure or uncontrolled hypertension,
• Hyponatremia,
• Nasal mucosal sores, edema, or infection.

During pregnancy and breastfeeding, use must be medically supervised.

Conclusion and Recommendations

Desmovital nasal spraycan reduce nighttime urination and improve sleep quality and daily comfort. Effective, safe treatment requires careful monitoring of dose, timing, and fluid restriction. Use only on a physician's recommendation.